Structuration nationale pour la prise en charge des lymphomes à petites (sprue réfractaire de type II) et grandes cellules associés à la maladie cœliaque

ArticleinOncologie 10(6):421-424 · May 2008with6 Reads
Impact Factor: 0.06 · DOI: 10.1007/s10269-008-0890-7

    Abstract

    Low-grade and overt lymphomas are rare and severe complications of the celiac disease. The diagnostic techniques and criteria to be used for these intestinal lymphomas are very specific; they have been developed recently and remain insufficiently known. Efficient treatment does not exist.
    Aims
    To homogenize and make available for all the diagnostic techniques and criteria of these complications, their follow-up and therapeutic management.
    Patients and methods
    Organization of a national network that will include 16 national centres. The technical means, skills and experience of the coordinating group (for phenotyping, histological, cytogenetic and molecular studies) will be available to all centres of the network. Clinical and biological data of the patients will be centralized and recorded on computer medical files and discussed during multidisciplinary committee meetings.
    Conclusion
    The “Lymphocœliaque” organization should improve the diagnosis and therapeutic management of celiac patients with lymphomas.